Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria
Crossref DOI link: https://doi.org/10.1186/s40064-015-1440-6
Published Online: 2015-12-01
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Jahn, B.
Rochau, U.
Kurzthaler, C.
Hubalek, M.
Miksad, R.
Sroczynski, G.
Paulden, M.
Kluibenschädl, M.
Krahn, M.
Siebert, U.
Funding for this research was provided by:
Oncotyrol (2073085)
License valid from 2015-12-01